Versigent Makes Its Public Market Debut on the New York Stock Exchange

New York, Wednesday, 1 April 2026.
Following its separation from Aptiv, Versigent officially enters the public markets today. CEO Joseph Liotine rings the NYSE opening bell, signaling strong momentum for second-quarter equities.